Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 2
2017 1
2018 3
2019 6
2020 4
2021 8
2022 8
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Results by year

Filters applied: . Clear all
Page 1
Fumarate hydratase-deficient renal cell carcinoma: A tumor with diverse morphology including cannibalism, lymphocytic emperipolesis, and defective autophagy.
Billis A, Assis-Mendonça GR, Tavares TF, Parreira K, Costa LBE, Barreto IS, Freitas LLL. Billis A, et al. Ann Diagn Pathol. 2022 Feb;56:151844. doi: 10.1016/j.anndiagpath.2021.151844. Epub 2021 Oct 27. Ann Diagn Pathol. 2022. PMID: 34753094
We report the clinicopathological findings of the first series of 3 patients from Brazil with fumarate hydratase-deficient renal cell carcinoma. The clinicopathological findings disclosed a very aggressive tumor. ...
We report the clinicopathological findings of the first series of 3 patients from Brazil with fumarate hydratase-deficient …
Fumarate hydratase-deficient renal cell carcinoma: a case report and review of the literature.
Lv Y, Song L, Hu M. Lv Y, et al. J Med Case Rep. 2023 Apr 20;17(1):182. doi: 10.1186/s13256-023-03841-0. J Med Case Rep. 2023. PMID: 37076922 Free PMC article. Review.
BACKGROUND: Fumarate hydratase-deficient renal cell carcinoma is a rare pathological subtype that was defined by the World Health Organization (WHO 5th edition) in 2022. ...The postoperative pathological diagnosis was fumarate h …
BACKGROUND: Fumarate hydratase-deficient renal cell carcinoma is a rare pathological subtype that …
Low-grade Oncocytic Fumarate Hydratase-deficient Renal Cell Carcinoma: An Update on Biologic Potential, Morphologic Spectrum, and Differential Diagnosis With Other Low-grade Oncocytic Tumors.
Hamza A, Sirohi D, Smith SC, Amin MB. Hamza A, et al. Adv Anat Pathol. 2021 Nov 1;28(6):396-407. doi: 10.1097/PAP.0000000000000321. Adv Anat Pathol. 2021. PMID: 34561376 Review.
Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is typically considered a high-grade, aggressive subtype of RCC that frequently arises in the setting of hereditary leiomyomatosis-renal cell carcinoma (HLRCC) syndrome. …
Fumarate hydratase-deficient renal cell carcinoma (FH-deficient RCC) is typically considered a hig …
Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study.
Nikolovski I, Carlo MI, Chen YB, Vargas HA. Nikolovski I, et al. Cancer Imaging. 2021 Feb 19;21(1):24. doi: 10.1186/s40644-021-00392-9. Cancer Imaging. 2021. PMID: 33608050 Free PMC article.
BACKGOUND: Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a subtype of RCC that is increasingly recognized pathologically. ...
BACKGOUND: Fumarate hydratase-deficient renal cell carcinoma (FH-RCC) is a subtype of RCC that is …
Approach for reclassification of collecting duct carcinoma and comparative histopathological analysis with SMARCB1/INI1-deficient renal cell carcinoma and fumarate hydratase-deficient renal cell carcinoma.
Kiyozawa D, Kohashi K, Takamatsu D, Iwasaki T, Shibata D, Tomonaga T, Tateishi Y, Eto M, Kinjo M, Nishiyama K, Taguchi K, Oshiro Y, Kuboyama Y, Furuya M, Oda Y. Kiyozawa D, et al. Hum Pathol. 2022 Jun;124:36-44. doi: 10.1016/j.humpath.2022.03.002. Epub 2022 Mar 16. Hum Pathol. 2022. PMID: 35306021 Review.
The Differential Diagnosis of Medullary-Based Renal Masses.
Baniak N, Tsai H, Hirsch MS. Baniak N, et al. Arch Pathol Lab Med. 2021 Sep 1;145(9):1148-1170. doi: 10.5858/arpa.2020-0464-RA. Arch Pathol Lab Med. 2021. PMID: 33406251 Free article. Review.
Other medullary-based malignancies included in the differential diagnosis include renal medullary carcinoma/renal cell carcinoma unclassified with medullary phenotype, fumarate hydratase-deficient renal cell carcinoma, and upper tract uro …
Other medullary-based malignancies included in the differential diagnosis include renal medullary carcinoma/renal cell carcinoma unclassifie …
36 results